has vaccine component
vaccinated in route
immunizes host
immunizes against pathogen
Severe acute respiratory syndrome coronavirus 2
Homo sapiens
intramuscular route
VLA2001
https://valneva.com/research-development/covid-19-vla2001/
vaccine
Philip Huang
A SARS-CoV-2 inactivated, Vero-cell based vaccine adjuvanted with aluminum and CpG 1018. It uses the manufacturing platform of Valneva’s commercial Japanese encephalitis (JE) vaccine
authorized inactivated COVID-19 vaccine